A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

December 2, 2022

Study Completion Date

December 9, 2022

Conditions
Parkinson Disease
Interventions
DRUG

Mesdopetam

Oral use

DRUG

Placebo

Oral use

Trial Locations (44)

11000

Clinical Hospital Center Zvezdara, Clinical department of Neurology, Belgrade

University Clinical Center of Serbia, Clinic for Neurology, Belgrade

16132

"IRCCS - Ospedale San Martino", Genova

30029

CHU Carémeau, Nîmes

30030

NeuroStudies.net, LLC, Decatur

33014

Life Medical Research Group Corp, Miami Gardens

33155

Avantis Clinical Research, Miami

Elias Research Associates (Allied Biomedical Research Institute), Miami

33175

Pharmax Research of South Florida, Inc., Miami

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

34000

University Clinical Center Kragujevac, Clinic for Neurology (Site 601), Kragujevac

University Clinical Center Kragujevac, Clinic for Neurology (Site 602), Kragujevac

35033

CHU Rennes-Pontchaillou, Rennes

35128

Azienda Ospedaliera di Padova, Padua

40536

University of Kentucky, Department of Neurology, Lexington

59037

Centre Hospitalier Regional Universitaire de Lille, Lille

74136

The Movement Disorder Clinic of Oklahoma, Tulsa

75390

University of Texas Southwestern Medical Center, Dallas

76031

CHU Charles Nicolle; Service de Neurologie, Rouen

80907

Colorado Springs Neurological Associates, Colorado Springs

84131

AOU San Giovanni di Dio e Ruggi d'Aragona, Clinica Neurologica, Salerno

85258

Movement Disorders Center of Arizona, Scottsdale

86021

CHU de Poitiers, Poitiers

87042

CHU Dupuytren 1 - Neurologie, Limoges

90806

Collaborative Neuroscience Research (CNS Research), Long Beach

94301

Parkinson's Disease and Movement Disorders Center of Silicon Valley, Palo Alto

99202

Inland Northwest Research, Spokane

3109601

Rambam Health Care Campus, Department of Neurology, Haifa

4941492

Rabin Medical Centre - Beilinson Hospital, Department of Neurology, Petah Tikva

5265601

The Chaim Sheba Medical Centre, Department of Neurology, Ramat Gan

6423906

Tel Aviv Sourasky Medical Centre; Movement Disorders Unit, Tel Aviv

9112001

Hadassah University Hospital-Ein Kerem, Department of Neurology, Jerusalem

00163

IRCCS San Raffaele Pisana, Roma

00168

Fondazione Policlinico Gemelli IRCCS, Roma

85-163

Centrum Medyczne Neuromed, Bydgoszcz

40-097

Specjalistyczna Praktyka Lekarska, Katowice

30-363

Centrum Medyczne PLEJADY, Krakow

30-539

Specjalistyczne Gabinety Sp z o.o., Krakow

31-505

Krakowska Akademia Neurologii, Krakow

32-600

Instytut Zdrowia, Oświęcim

41-100

Neuro-Care, Siemianowice Śląskie

01-684

Centrum Medyczne NeuroProtect, Warsaw

02-042

Next Stage sp.z o.o., Warsaw

41-807

ClinHouse Centrum Medyczne, Zabrze

All Listed Sponsors
lead

Integrative Research Laboratories AB

INDUSTRY

NCT04435431 - A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia | Biotech Hunter | Biotech Hunter